Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 2

1(14.3%)

7Total

N/A(6)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04724824Not ApplicableCompleted

Validation of a Brain-Computer Interface for Stroke Neurological Upper Limb Rehabilitation

Role: collaborator

NCT05279534Not ApplicableTerminated

Efficacy and Safety of L. Plantarum and P. Acidilactici in Children With Upper Respiratory Tract Infections

Role: collaborator

NCT03732586Not ApplicableCompleted

Effect of Omega 5 Fatty Acid as an Adyuvant Treatment to Prednisone in Patients With Severe Alcoholic Hepatitis

Role: lead

NCT05685641Not ApplicableUnknown

Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City

Role: collaborator

NCT04096222Unknown

Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients

Role: collaborator

NCT04517422Not ApplicableCompleted

Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19

Role: collaborator

NCT04388410Phase 2Unknown

Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19

Role: collaborator

NCT03215979Not ApplicableUnknown

Use of Platelet-enriched Plasma During Auricular Reconstruction

Role: lead

NCT01418287Completed

Characterization of Influenza-like Illness in Mexico

Role: collaborator

All 9 trials loaded